A novel method of generating prostate cancer metastases from orthotopic implants

Prostate

Volumn 56, Issue 2, 2003, Pages 110-114

  Corey, Eva ^a   Quinn, Janna E ^a   Vessella, Robert L ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Metastasis; Prostate cancer; Prostate specific antigen; Xenografts

Indexed keywords

ANDROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER GROWTH; CANCER MODEL; CONTROLLED STUDY; HORMONE SENSITIVITY; METASTASIS POTENTIAL; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; SCID MOUSE; TUMOR VOLUME; WILD TYPE; XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; CHEMISTRY; DISEASE MODEL; HUMAN; LIVER TUMOR; LUNG TUMOR; MALE; METASTASIS; METHODOLOGY; MOUSE MUTANT; PANCREAS TUMOR; PROSTATE TUMOR;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 0041307303     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10235     Document Type: Article

References (14)

1. Ware JL, Paulson DF, Mickey GH, Webb KS. Spontaneous metastasis of cells of the human-prostate carcinoma cell-line PC-3 in Athymic nude-mice. J Urol 1982;128:1064-1067.
2. Sato N, Cleave ME, Bruchovsky N, Rennie PS, Beraldi E, Sullivan LD. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice. Cancer Res 1997;57:1584-1589.
3. Rembrink K, Romijn Jc, van der Kwast TH, Rubben H, Schoder FH. Orthopic implantation of human prostate cancer cell lines: A clinically relevant animal model for metastatic prostate cancer. Prostate 1997;31:168-174.
4. Stephenson RA, Dinney CP, Gohji K, Ordonez NG, Killion JJ, Fidler IJ. Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst 1992;84:951-957.
5. Pettaway CA, Pathak S, Greene G, Ramirez E, Wilson MR, Killion JJ, Fidler IJ. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice. Clin Cancer Res 1996;2:1627-1636.
6. Thalmann GN, Anezinis PE, Chang S, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC, Chung LWK. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 1994;54:2577-2581.
7. Wu TT, Sikes RA, Cui Q, Thalmann GN, Kao C, Murphy CF, Yang H, Zhau HE, Balian G, Chung LW. Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer 1998;77:887-894.
8. Shevrin DH, Kukreja SC, Ghosh L, Lad TE. Development of skeletal metastasis by human prostate cancer in athymic nude mice. Clin Exp Metastasis 1988;5:401-409.
9. Guise TA. Parathyroid hormone-related protein and bone metastases. Cancer 1997;80:1572-1580.
10. Tennant TR, Kim H, Sokoloff M, Rinker-Schaeffer CW. The Dunning model. Prostate 2000;43:295-302.
11. Hall SJ, Thompson TC. Spontaneous but not experimental metastatic activities differentiate primary tumor-derived vs metastasis-derived mouse prostate cancer cell lines. Clin Exp Metastasis 1997;15:630-638.
12. Zhau HY, Chang SM, Chen BQ, Wang Y, Zhang H, Kao C, Sang QA, Pathak SJ, Chung LW. Androgen-repressed phenotype in human prostate cancer. Proc Natl Acad Sci USA 1996;93:15152-15157.
13. Ellis WJ, Vessella RL, Buhler KR, Bladou F, True LD, Bigler SA, Curtis D, Lange PH. Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23. Clin Cancer Res 1996;2:1039-1048.
14. Corey E, Quinn JE, Buhler KR, Nelson PS, Machoska JA, True LD, Vessela RL, LuCap 35: A New Model of Prostate Cancer Progression to Androgen Independence. Prostate 2003;55:239-246.